medigraphic.com
SPANISH

Revista de Nefrología, Diálisis y Trasplante

ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 3

<< Back Next >>

Rev Nefrol Dial Traspl 2022; 42 (3)

Acute kidney injury secondary to post-phacoemulsification treatment with acetazolamide. A side effect of a widely used drug. Case report

López-Romero LC, Poma SF, Viejo BI
Full text How to cite this article

Language: Spanish
References: 9
Page: 248-252
PDF size: 256.70 Kb.


Key words:

acute kidney injury, acetazolamide, crystalluria, renal dialysis.

ABSTRACT

Acetazolamide (ACTZ) is a drug that is used frequently, especially in the treatment of glaucoma. It reduces the secretion of hydrogen in the proximal renal tubule and increases the elimination of bicarbonate and water. Its side effects include nausea, vomiting, abdominal pain, electrolyte imbalances. However, the cases of acute kidney injury (AKI) described are very rare.
ACTZ is known to promote the formation of kidney stones due to its effects on urinary pH due to its chronic use, and when excreted in an acidic urinary environment, it can lead to the formation of crystals in the kidney tubules and cause kidney damage. Here we describe a rare case of acute kidney injury that required dialysis secondary to the use of low-dose acetazolamide after cataract surgery.
AKI due to acute crystalluria is a potentially severe complication. With the description of this case, we want to emphasize the importance of knowing this rare adverse effect since an early diagnosis that requires high clinical suspicion can avoid complications.


REFERENCES

  1. Mincione F, Scozzafava A, Supuran CT. Thedevelopment of topically acting carbonic anhydraseinhibitors as antiglaucoma agents. Curr Pharm Des.2008;14(7):649–54.

  2. Farzam K, Abdullah M. Acetazolamide. 2020 Nov27. In: StatPearls. Treasure Island (FL): StatPearlsPublishing; 2020.

  3. Van Berkel MA, Elefritz JL. Evaluating off-labeluses of acetazolamide. Am J Health Syst Pharm.2018;75(8):524-31.

  4. Howlett SA. Renal failure associated with acetazolamidetherapy for glaucoma. South Med J. 1975;68:504-506.

  5. Higenbottam T, Ogg CS, Saxton HM. Acute renalfailure from the use of acetazolamide (Diamox).Postgrad Med J. 1978;54:127-128.

  6. Glushien AS, Fisher ER. Renal lesions of sulfonamidetype after treatment with acetazolamide (diamox). JAm Med Assoc. 1956;160:204-206.

  7. Rossert, J, Rondeau, E, Jondeau, G. Tamm-Horsfall protein accumulation in glomeruli duringacetazolamide-induced acute renal failure. Am JNephrol. 1989;9:56-57.

  8. Neyra JA, Alvarez-Maza JC, Novak JE. Anuric acutekidney injury induced by acute mountain sicknessprophylaxis with acetazolamide. J Investig Med High-Impact Case Rep. 2014;2(2):2324709614530559.

  9. Lawson C, Morris L, Wilson V, et al. Hemorrhagicanuria with acute kidney injury after a single doseof acetazolamide: A case study of a rare side effect.Cureus. 2020;12(8):e10107.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Nefrol Dial Traspl. 2022;42